FuzzyBot: Importing a new version from external source

2024-03-21T04:16:40Z

Importing a new version from external source

New page

During pregnancy, spontaneous hyperglycemia can develop and lead to [[Gestational diabetes|gestational diabetes mellitus (GDM)]], a frequent pregnancy complication . With a prevalence of 6-20% among pregnant women globally, gestational diabetes mellitus (GDM) is defined as any degree of glucose intolerance developing or initially recognized during pregnancy. [[NPH insulin|Neutral protamine Hagedorn]] (NPH) insulin has been the cornerstone of insulin therapy during pregnancy, administered two to four times per day. Women with GDM and pregnant women with type I diabetes mellitus who frequently check their blood glucose levels and utilize glucose monitoring equipment for doing so, use continuous insulin infusion of a rapid-acting insulin analogue, such as [[Insulin lispro|lispro]] and [[Insulin aspart|aspart.]] However, a number of considerations go into choosing a regimen for administering insulin to patients. When managing GDM in pregnant women, these guidelines are crucial and can vary depending on certain physiological and interestingly the sociocultural environment as well. The current perinatal guidelines recommend a low daily dose of insulin and take into account the woman's physiological features and the frequency of self-monitoring. The importance of using specialized insulin therapy planning based on parameters like those stated above rather than a broad approach is emphasized.

Translations:Insulin (medication)/60/en - Revision history

FuzzyBot: Importing a new version from external source